W. M. Alberts, MD, MBA

Where You Are:

W. M. Alberts, MD, MBA


For Consultation Requests or Referrals: (813) 745-8467


The American College of Chest Physicians has awarded W. Michael Alberts, M.D., MBA the honorary title of Master Fellow.

 The designation is the highest level of recognition awarded by the organization and is given for achievement of professional prominence in chest medicine.  Alberts was selected for his leadership, contributions to the field of chest medicine, clinical practice, quality improvement, medical education and years of outstanding service. 


          •  Internal Medicine - Pulmonary Disease

          •  University of California, San Diego, California - Pulmonary and Critical Care Medicine

          •  Ohio State University Hospital, Columbus, Ohio - Internal Medicine

          •  University of Illinois - MD

  • Nanavaty P, Alvarez MS, Alberts WM. Lung cancer screening: advantages, controversies, and applications. Cancer Control. 2014 Jan;21(1):9-14. Pubmedid: 24357736.

  • Detterbeck FC, Lewis SZ, Diekemper R, Addrizzo-Harris D, Alberts WM. Executive Summary: Diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence-based clinical practice guidelines. Chest. 2013 May;143(5 Suppl):7S-37S. Pubmedid: 23649434.

  • Alberts WM. Introduction to the Third Edition: Diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence-based clinical practice guidelines. Chest. 2013 May;143(5 Suppl):38S-40S. Pubmedid: 23649431.

  • Alberts WM. Updated ACCP Guidelines for the diagnosis and management of lung cancer: what are the important changes in recommendations?. Pol Arch Med Wewn. 2008 Jan-Feb;118(1-2):4-5. Pubmedid: 18405165.

  • Alberts WM. Pulmonary manifestations of the Churg-Strauss syndrome and related idiopathic small vessel vasculitis syndromes. Curr Opin Pulm Med. 2007 Sep;13(5):445-450. Pubmedid: 17940492.

  • Gray J, Alberts W, Bepler G. Statins and lung cancer risk. Chest. 2007 May;131(5):1274-1275. Pubmedid: 17494775.

  • Alberts W. Follow up and surveillance of the patient with lung cancer: what do you doafter surgery. Respirology. 2007 Jan;12(1):16-21. Pubmedid: 17207020.

  • Alberts W. Lung disease and the lightest of metals. Chest. 2004;126:1730-1732. Pubmedid: 15596666.

  • Alberts W. Eosinophilic interstitial lung disease. Curr Opin Pulm Med. 2004;10(5):419-424. Pubmedid: 15316442.

  • Nordquist L, Simon G, Cantor A, Alberts W, Bepler G. Improved survival in never-smokers vs current smokers with primary adenocarcinoma of the lung. Chest. 2004;126(2):347-351. Pubmedid: 15302716.

  • Alberts W, Bepler G, Hazelton T, Ruckdeschel J, Williams JH J. Lung cancer. Practice organization. Chest. 2003;123:332S-337S. Pubmedid: 12527588.

  • Alberts W. Too many journals, too little time. Chest. 2000;118(1):1-1. Pubmedid: 10893345.

  • Alberts W. The future and lung cancer: room for optimism?. Cancer Control. 2000;7(1):13-14. Pubmedid: 10777341.

  • Alberts W. 72-year-old man with fever, skin lesion, and consolidation on chest radiograph. Chest. 2000;118(3):861-862. Pubmedid: 10988216.

  • Alberts WM. Divalent cations and bronchodilation in asthma. Crit Care Med. 1999 Jun;27(6):1056-1057. Pubmedid: 10397201.

  • Alberts W. Using inhalation challenge tests to evaluate occupational asthma. J Respir Dis. 1999;20(7):464-465. Pubmedid: noPMID.

  • Alberts W. Reactive airways dysfunction syndrome. Advance For Managers Of Respiratory Care. 1998;7(2):30-34. Pubmedid: noPMID.

  • Alberts W. 'Circa Menstrual' rhythmicity and asthma. Chest. 1997 Apr;111(4):840-842. Pubmedid: 9106554.

  • Alberts W. Respiratory hazards and the healthcare worker: infectious hazards. J Respir Dis. 1997;18(5):495-503. Pubmedid: noPMID.

  • Alberts W. Respiratory hazards and the healthcare worker: physical, radiation, and psychosocial hazards. J Respir Dis. 1997;18(4):406-413. Pubmedid: noPMID.

  • Perez JE, Alberts WM, Mamal JJ. Delayed tension pneumothorax after laparoscopy. Surg Laparosc Endosc. 1997;7(1):70-72. Pubmedid: 9116956.

  • Alberts W. Respiratory hazards and the healthcare worker: chemical hazards. J Respir Dis. 1997;18(6):592-602. Pubmedid: noPMID.

  • Alberts W. Pulmonary complications of cancer treatment. Curr Opin Oncol. 1997;9(2):161-169. Pubmedid: 9161795.

  • Alberts W, Brooks S. Reactive airwarys dysfunction syndrome. Curr Opin Pulm Med. 1996;2:104-110. Pubmedid: 9363124.

  • Rolfe M, Alberts W. The chronic persistent cough. Compr Ther. 1996;22(10):615-621. Pubmedid: 8950077.

  • Alberts W, do Pico G. Reactive airways dysfunction syndrome. Chest. 1996;109:1618-1626. Pubmedid: 8769520.

  • Antonia S, Wagner, Jr. H, Williams, Jr. C, Alberts W, Hubbell D, Robinson L, Hilstro J, Ruckdeschel J. Concurrent paclitaxel/cisplatin with thoracic radiation in patients with stage IIIA/B non-small cell carcinoma of the lung. Semin Oncol. 1995 Aug;22(4 Suppl 9):34-37. Pubmedid: 7644926.

  • Alberts W. Business and management training for physicians: CME or the third degree. Chest. 1995;108:1711-1717. Pubmedid: 7497784.

  • Brooks S, Alberts W. Occupational asthma. Postgrad Med. 1995;97:91-104. Pubmedid: noPMID.

  • Alberts W, Brooks S. Occupational asthma. Postgrad Med J. 1995;97(6):91-104. Pubmedid: 7777449.

  • Alberts WM. Indoor air pollution: NO, NO2, CO, and CO2. J Allergy Clin Immun. 1994 Aug;94(2 Pt 2):289-295. Pubmedid: 8077581.

  • Alberts W, Ferris M, Brooks S, Goldman A. The FEF 25-75% and the clinical diagnosis of asthma. Ann Allergy. 1994;73:221-225.

  • Alberts W. Indoor air pollution: NO, NO(2), CO, and CO(2). J Immunol. 1994;94:289-295.

  • Abel W, Alberts W. Effect of eliminating the same challenge step on the results of bronchoprovocation challenge testing. Chest. 1994;106:125s-125s.

  • Alberts W, Rumbak M, Walsh F. Diagnostic techniques in lung cancer. Cancer Control. 1994;1:446-454.

  • Alberts W. Building-related illness: what it is, what you can do. J Respir Dis. 1994;15(10):899-962.

  • Ferris M, Alberts W. Reproducibility of recommended indices used to report the response to a methacholine bronchial provocation test. Chest. 1993;104:62s-62s.

  • Ferris M, Alberts W. Can the baseline FEF 25-75 predict the results of a methacholine bronchial provocation test?. Am Rev Respir Dis. 1993;147:A829-A829.

  • Alberts W. Common causes of occupational asthma. J Respir Dis. 1993;14:564-578.

  • Alberts W. Occupational asthma in the respiratory care worker. Respir Care. 1993;38:997-1004.

  • Alberts W, Brooks S. Advances in occupational asthma. Clin Chest Med. 1992;13(2):281-302.

  • Alberts W, Goldman A. Bronchodilator testing "confidence intervals" based on the level of bronchial responsiveness. Chest. 1992;102:737-741.

  • Alberts WM, Williams JH, Ramsdell JW. Metabolic acidosis as a presenting feature in acute asthma. Ann Allergy. 1986 Aug;57(2):107-109. Pubmedid: 3090909.

  • Alberts WM, Ferguson PR, Ramsdell JW. Preparation and handling of methacholine chloride testing solutions. Effect of the hygroscopic properties of methacholine. Am Rev Respir Dis. 1983 Mar;127(3):350-351. Pubmedid: 6338784.

  • Alberts W. Occupational asthma. In: Pulmonary: pearls of wisdom. Boston, MA: Boston Medical Publishing; 1999.

  • Simon G, Ruckdeschel J, Williams C, Cantor A, Antonia S, Haura E, Rocha C, Chiappori A, Wagner H, Robinson L, Sommers E, Alberts M, Bepler G. Gefitinib (ZD1839) in previously treated advanced non-small-cell lung cancer: experience from a single institution. Cancer Control. 10(5):388-395. Pubmedid: 14581894.

  • Alberts W. Business and management training for physicians. In: Silver J, ed. The business of medicine. Hanley And Belfus; 1998;293-308.

  • Rumbak M. High altitude and diving lung disease. In: Alberts M, ed. Occupational Lung Disease. Northbrook, IL: American College Of Chest Physicians; 1998.

  • Alberts W. Physician leadership for quality in a price-competitive world. In: Kaufman R, ed. The business side of medicine: a survival primer for medical students and residents. Tampa, FL: ACPE; 1999.

  • Alberts W. Occupational asthma. In: Seymour W, ed. Pulmonary: pearls of wisdom. Boston, MA: Boston Medical Publishing; 1999.

W. Michael Alberts, MD, MBA is Professor of Oncology and Medicine in the Department of Interdisciplinary Oncology at the University of South Florida College of Medicine in Tampa, Florida.  He is the Chief Medical Officer at the H. Lee Moffitt Cancer Center and Research Institute.  Dr. Alberts received his MD from the University of Illinois.  He completed a residency in Internal Medicine at the Ohio State University and a fellowship program in Pulmonary and Critical Care Medicine at the University of California at San Diego.  Dr. Alberts earned an MBA degree from the University of South Florida.  Dr. Alberts is a Past-President of the American College of Chest Physicians.  Dr. Alberts' research and scholarly interests include the diagnosis and management of lung cancer and the business of medicine.

TOOLS:   Font Size small font resizer separator font resizer separator big font resizer
 |  Site Map  |  Privacy Policy  |  Terms and Conditions